Jurisdictions that legalized recreational cannabis saw increased potency, more cannabis-related emergency visits, and declining risk perception — prompting calls for health-focused regulation.
Anyone interested in whether legalization has made cannabis safer or just more accessible.
What the researchers found
This review synthesized what had been observed in jurisdictions that legalized recreational cannabis and found a consistent pattern: potency increased as commercial producers optimized for THC content, cannabis-related emergency department visits rose, and public perception of risk declined — particularly among young people.
The authors argued that legalization frameworks had primarily focused on market economics — creating legal supply chains, diverting profits from illegal markets, and reducing prohibition costs — while underweighting health and safety considerations. The language around commercial cannabis tended to trivialize risk, and increased visibility in public spaces contributed to normalization.
The paper called for regulation models that prioritized individual health and safety alongside market goals, including potency limits, restrictions on marketing, and better public education about dose-dependent risks.
Why it matters
This paper captured the gap between the promise of legalization and its early implementation. Legal cannabis was supposed to be safer cannabis — regulated, tested, labeled. But in practice, the market pushed potency higher (because that's what sells), risk perception dropped (because legal equals safe in many people's minds), and ER visits increased.
None of this means legalization was wrong. It means the regulatory frameworks weren't designed with health outcomes as the primary goal. The alcohol parallel is instructive: alcohol is legal, but its regulation has evolved over decades to include advertising restrictions, age limits, taxation, and impaired driving laws. Cannabis regulation was still in its early stages.
The numbers in context
• Cannabis potency increased in jurisdictions with legal recreational markets
• Cannabis-related ER visits increased post-legalization
• Risk perception declined, particularly among adolescents and young adults
• THC and CBD are the most studied of 100+ cannabinoids in the plant
How the study worked
Narrative review examining post-legalization data on cannabis potency, emergency department presentations, risk perception surveys, and regulatory frameworks across jurisdictions with legal recreational cannabis. Published in Medicine, Science and the Law.
Who was studied
Discussion of cannabis use trends among adolescents and young adults in jurisdictions with legalized non-medical cannabis.
What this study cannot tell us
Narrative review without systematic search methodology. Post-legalization trends may reflect increased reporting and detection rather than true increases in harm. The correlation between legalization and increased ER visits doesn't account for confounders like population growth, tourism, or changes in hospital coding. Different jurisdictions legalized under different rules, limiting generalizability.
How to read the evidence
Narrative review summarizing observational trends. Identifies consistent patterns but cannot prove causal links between legalization and specific health outcomes.
When this study was published
Published in 2020. Legalization has continued expanding, with more post-legalization health data now available.
The bigger picture
Published in 2020, this review was part of a growing chorus of public health voices arguing that cannabis legalization needed a course correction — not back toward prohibition, but toward smarter regulation. Potency caps, marketing restrictions, and mandatory health warnings were all on the table. The tension between commercial interests and public health was becoming the defining policy challenge of legal cannabis.
Replication
Not stated in abstract.
Funding
Not reported in abstract.
Conflicts of interest
Not reported in abstract.
Questions still open
- Would THC potency caps reduce emergency department visits?
- How should cannabis marketing be regulated to avoid normalizing risky use patterns?
- Can risk perception campaigns effectively counteract the 'legal means safe' assumption?
Common questions
Did legalization make cannabis safer?
Why did ER visits go up after legalization?
Read the original research
Cannabis knowledge and implications for health: Considerations regarding the legalization of non-medical cannabis.
Medicine, science, and the law, 60(4), 309-314
Medicine, Science and the Law is a peer-reviewed journal focusing on the intersection of law and health sciences.
Citation
Zamengo, Luca; Frison, Giampietro; Zwitser, Guus; Salomone, Alberto; Freeman, Tom P. (2020). Cannabis knowledge and implications for health: Considerations regarding the legalization of non-medical cannabis.. Medicine, science, and the law, 60(4), 309-314. https://doi.org/10.1177/0025802420934255